Hualan Biological proposes significant interim dividend for 2025

Hualan Biological Engineering announced it will convene its second extraordinary general meeting of shareholders on September 22, 2025, to vote on a proposed interim dividend for the first half of 2025. The company’s board of directors, which met on August 27, 2025, approved a cash dividend of CNY 5 per 10 shares (tax inclusive) based on a total share capital of 1,827,456,666 shares as of June 30, 2025. This translates to a total cash payout of CNY 913,728,333.00, representing 177.13% of the net profit attributable to shareholders in the first half of 2025.

The proposed distribution does not include bonus shares or conversion of capital reserves to increase share capital. The distribution considers the company's profitability, cash flow, debt-paying ability, and future capital requirements, aligning with Hualan Biological’s commitment to shareholder returns and a quality-driven, stable development strategy.

Shareholders can participate in the meeting either in person or via online voting through the Shenzhen Stock Exchange systems. The equity registration date for the meeting is September 17, 2025.